SporeGen® Awarded EMI-TB Grant

SporeGen® has been made a partner on the Horizon 2020 EMI-TB Grant focusing on developing innovative mucosal vaccines to TB, utilising the SporeGen® “SporeVax” technology. The grant is led by

Read More


  • February 12, 2015
  • SporeGen

SporeGen®is proud to be working with PATH and Dr. R. Aroian (University of Massachusetts) on a project that could ultimately lead to a significant impact on soil-transmitted helminth infections

Read More

New EMI-TB website launched

The Horizon 2020 EMI-TB Grant, focusing on developing innovative mucosal vaccines for TB, of which SporeGen® is a contributing partner, has launched a new website. The website will develop over the

Read More

SporeGen® awarded SAPHIR Grant

The SAPHIR project is an EU funded project whose full title is: Strengthening Animal Production and Health through the Immune Response. The general objective of SAPHIR is to generate

Read More
1 2 3 4 5